Proton Versus Photon Adjuvant Radiotherapy: A Multicenter Comparative Evaluation of Recurrence Following Spinal Chordoma Resection

被引：0
|
作者：
Ghaith, Abdul Karim
El-Hajj, Victor Gabriel
Nguyen, Ryan
Battistin, Umberto
Akinduro, Oluwaseun
Bydon, Mohamad
Abode-Iyamah, Kingsley O.
机构：
来源：
NEUROSURGERY | 2025年 / 71卷
关键词：
D O I：
10.1227/neu.0000000000003360_2005
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2005
引用
收藏
页码：240 / 241
页数：2
相关论文
共 40 条
  • [21] Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis
    Se-Woong Chun
    Kyung Min Kim
    Min-Sung Kim
    Ho Kang
    Yun-Sik Dho
    Youngbeom Seo
    Jin Wook Kim
    Yong Hwy Kim
    Chul-Kee Park
    Radiation Oncology, 16
  • [22] Comparative effectiveness of proton therapy versus photon therapy as part of concurrent chemo-radiotherapy for locally advanced cancer
    Larnaudie, Audrey
    Le Guevelou, Jennifer
    Thariat, Juliette
    BULLETIN DU CANCER, 2020, 107 (04) : 405 - 407
  • [23] Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis
    Xu, Xiao
    Wang, Ming-Da
    Xu, Jia-Hao
    Fan, Zhong-Qi
    Diao, Yong-Kang
    Chen, Zhong
    Jia, Hang-Dong
    Liu, Fu-Bao
    Zeng, Yong-Yi
    Wang, Xian-Ming
    Wu, Han
    Qiu, Wei
    Li, Chao
    Pawlik, Timothy M.
    Lau, Wan Yee
    Shen, Feng
    Lv, Guo-Yue
    Yang, Tian
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [24] Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies (vol 56, pg 1060, 2017)
    Vogel, J.
    Lin, L.
    Simone, C. B., II
    Berman, A. T.
    ACTA ONCOLOGICA, 2018, 57 (06) : 873 - 873
  • [25] Epicardial versus endocardial strain and strain rate evaluation in oncological patients undergoing a new radiotherapeutic treatment: proton beam versus photon (x-ray) radiotherapy
    Bruno, G.
    Di Stefano, C.
    Mutter, R. W.
    Laack, N. N.
    Kahila, M. M.
    Whitaker, T. J.
    Pellikka, P. A.
    Pumper, G. M.
    Herrmann, J.
    Villarraga, H. R.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1090 - 1090
  • [26] A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression - Final results of a multicenter study
    Rades, D
    Fehlauer, F
    Stalpers, LJA
    Wildfang, I
    Zschenker, O
    Schild, SE
    Schmoll, HJ
    Karstens, JH
    Alberti, W
    CANCER, 2004, 101 (11) : 2687 - 2692
  • [27] Evaluation of machine learning versus Cox regression in identification of factors predicting recurrence following resection of non-small cell lung cancer
    Blayney, J. K.
    Grills, C. M.
    Jithesh, P. V.
    Wistuba, I. I.
    Jacobson, M.
    O'Byrne, K. J.
    Kerr, K. M.
    Scagliotti, G.
    Holt, R. J.
    Fennell, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol
    Bekelman, Justin E.
    Lu, Hien
    Pugh, Stephanie
    Baker, Kaysee
    Berg, Christine D.
    de Gonzalez, Amy Berrington
    Braunstein, Lior Z.
    Bosch, Walter
    Chauhan, Cynthia
    Ellenberg, Susan
    Fang, L. Christine
    Freedman, Gary M.
    Hahn, Elizabeth A.
    Haffty, B. G.
    Khan, Atif J.
    Jimenez, Rachel B.
    Kesslering, Christy
    Ky, Bonnie
    Lee, Choonsik
    Lu, Hsiao-Ming
    Mishra, Mark V.
    Mullins, C. Daniel
    Mutter, Robert W.
    Nagda, Suneel
    Pankuch, Mark
    Powell, Simon N.
    Prior, Fred W.
    Schupak, Karen
    Taghian, Alphonse G.
    Ben Wilkinson, J.
    MacDonald, Shannon M.
    Cahlon, Oren
    BMJ OPEN, 2019, 9 (10):
  • [29] IMbrave050: Phase 3 study of adjuvant atezolizumab plus bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following resection or ablation
    Trojan, J.
    Chow, P.
    Chen, M.
    Cheng, A-L
    Kaseb, A.
    Kudo, M.
    Lee, H. C.
    Yopp, A.
    Zhou, J.
    Wang, L.
    Wen, X.
    Heo, J.
    Tak, W-Y
    Nakamura, S.
    Numata, K.
    Uguen, T.
    Hsieh, D.
    Cha, E.
    Hack, S. P.
    Lian, Q.
    Spahn, J.
    Wu, C.
    Qin, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 239 - 239
  • [30] Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
    Pal, Sumanta Kumar
    Uzzo, Robert
    Karam, Jose Antonio
    Master, Viraj A.
    Donskov, Frede
    Suarez, Cristina
    Albiges, Laurence
    Rini, Brian
    Tomita, Yoshihiko
    Kann, Ariel Galapo
    Procopio, Giuseppe
    Massari, Francesco
    Zibelman, Matthew
    Antonyan, Igor
    Huseni, Mahrukh
    Basu, Debasmita
    Ci, Bo
    Leung, William
    Khan, Omara
    Dubey, Sarita
    Bex, Axel
    LANCET, 2022, 400 (10358): : 1103 - 1116
1234